Humana and DrFirst Partner on Innovation to Fill Gaps in Care, Improve Outcomes for Patients with Diabetes and Other Chronic Conditions

13.08.25 14:04 Uhr

Werte in diesem Artikel
Aktien

234,90 EUR 16,00 EUR 7,31%

Program Designed to Increase Use of Recommended Medication Therapy by Connecting with Providers in Workflow

LOUISVILLE, Ky. and ARLINGTON, Va., Aug. 13, 2025 /PRNewswire/ -- Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, and health technology pioneer DrFirst today announced the launch of a program designed to close gaps in care for patients with chronic health conditions like diabetes and cardiovascular disease while helping health care providers take timely, informed action. The first phase of this novel program aims to increase the use of statin therapy among eligible patients, aligning with a key quality metric from the Centers for Medicare & Medicaid Services (CMS).

Since 2000, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. More than 350,000 prescribers, 71,000 pharmacies, 300 EHRs and HIS, and more than 2,000 hospitals in the U.S. and Canada use DrFirst to improve workflows, expedite secure collaboration, and drive better patient outcomes. Visit www.drfirst.com or @DrFirst. (PRNewsfoto/DrFirst)

The use of statins for certain Medicare patients is associated with lower cardiovascular risk, better outcomes and reduced health care costs. To address this, Humana is partnering with DrFirst to connect with prescribers within the clinical workflow. Using the DrFirst prescription orchestration platform, Humana can now initiate new prescription recommendations for these high-risk patients and submit them to the health care provider for consideration. With one click, the provider can approve the prescription recommendation and generate a new prescription or note why it is not an appropriate choice for the patient.

"We're not just flagging care opportunities—we're making sure they get to providers in a way that's timely and easy to act on," said Bethanie Stein, Pharm.D., President, Pharmacy at Humana. "By reaching providers in their workflow, we're freeing them to focus on patient care, which in turn can help address gaps in care, promote quality and lead to better health outcomes."

The DrFirst prescription orchestration platform is a smart, flexible solution that turns disconnected workflows into real-time clinical collaboration. The rules-based system enables real-time interoperability among health care stakeholders—including health care providers, pharmacies, and payers—to close critical gaps in patient information and collaborate to improve patient outcomes.

"This partnership is about more than innovative technology; it's about better patient outcomes," said Laizer Kornwasser, DrFirst CEO. "As a company dedicated to taking the friction out of health care, it's especially meaningful to introduce an entirely new approach to medication management." Because DrFirst e-prescribing technology is used in over 270 EHRs, the prescription orchestration platform can be quickly implemented in workflow across care settings.

The collaboration builds on a decade-long track record of innovation between Humana and DrFirst. In 2015, the companies partnered to introduce the first real-time prescription benefit tool, enabling providers to view patient-specific coverage, costs and prior authorization requirements at the point of prescribing.

About Humana

Humana Inc. (NYSE: HUM) is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

About DrFirst

For 25 years, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare workflows and help patients start and stay on therapy with end-to-end solutions that enhance prescription access, affordability, and adherence. DrFirst has recently won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors. Our solutions help 100 million patients a year and are used by more than 450,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit DrFirst.com and follow @DrFirst. 

Media contact:

DrFirst:

Katlyn Nesvold, Amendola Communications
PH 715-559-0046 knesvold@acmarketingpr.com

Humana:

Mark Mathis
Humana Corporate Communications
mmathis@humana.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/humana-and-drfirst-partner-on-innovation-to-fill-gaps-in-care-improve-outcomes-for-patients-with-diabetes-and-other-chronic-conditions-302528163.html

SOURCE DrFirst

In eigener Sache

Übrigens: Humana und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Humana

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Humana

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Humana Inc.

Wer­bung

Analysen zu Humana Inc.

DatumRatingAnalyst
12.08.2019Humana OverweightCantor Fitzgerald
13.09.2018Humana OverweightBarclays Capital
09.11.2017Humana Sector PerformRBC Capital Markets
20.10.2017Humana OutperformBMO Capital Markets
05.04.2017Humana HoldDeutsche Bank AG
DatumRatingAnalyst
12.08.2019Humana OverweightCantor Fitzgerald
13.09.2018Humana OverweightBarclays Capital
20.10.2017Humana OutperformBMO Capital Markets
24.01.2017Humana HoldStifel, Nicolaus & Co., Inc.
05.05.2016Humana BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
09.11.2017Humana Sector PerformRBC Capital Markets
05.04.2017Humana HoldDeutsche Bank AG
07.12.2016Humana HoldCantor Fitzgerald
13.10.2016Humana Sector PerformRBC Capital Markets
22.07.2016Humana Mkt PerformFBR Capital
DatumRatingAnalyst
14.03.2008Humana neues KurszielLehman Brothers Inc.
03.02.2006Update Humana Inc.: UnderperformCredit Suisse First Boston
26.01.2006Update Humana Inc.: ReduceUBS

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Humana Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen